Skip to main content
NCBI home page
Heart logoLink to Heart
. 1996 Nov;76(3 Suppl 3):98–103. doi: 10.1136/hrt.76.3_suppl_3.98

The renin-angiotensin system and the heart: beyond 2000

T Morgan 1,2, H R Brunner 1,2
PMCID: PMC484496  PMID: 8983669

Full text

PDF
98

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cambien F., Poirier O., Lecerf L., Evans A., Cambou J. P., Arveiler D., Luc G., Bard J. M., Bara L., Ricard S. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 1992 Oct 15;359(6396):641–644. doi: 10.1038/359641a0. [DOI] [PubMed] [Google Scholar]
  2. Campbell D. J., Kladis A., Duncan A. M. Nephrectomy, converting enzyme inhibition, and angiotensin peptides. Hypertension. 1993 Oct;22(4):513–522. doi: 10.1161/01.hyp.22.4.513. [DOI] [PubMed] [Google Scholar]
  3. Chiu A. T., McCall D. E., Ardecky R. J., Duncia J. V., Nguyen T. T., Timmermans P. B. Angiotensin II receptor subtypes and their selective nonpeptide ligands. 1990-1991 WinterReceptor. 1(1-2):33–40. [PubMed] [Google Scholar]
  4. Cushman D. W., Wang F. L., Fung W. C., Harvey C. M., DeForrest J. M. Differentiation of angiotensin-converting enzyme (ACE) inhibitors by their selective inhibition of ACE in physiologically important target organs. Am J Hypertens. 1989 Apr;2(4):294–306. doi: 10.1093/ajh/2.4.294. [DOI] [PubMed] [Google Scholar]
  5. Danser A. H., Schalekamp M. A. Is there an internal cardiac renin-angiotensin system? Heart. 1996 Nov;76(3 Suppl 3):28–32. doi: 10.1136/hrt.76.3_suppl_3.28. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Di Nicolantonio R., Silvapulle M. J., Spargo S., Morgan T. O. High salt diet decreases longevity in the spontaneously hypertensive rat. Clin Exp Pharmacol Physiol. 1988 Apr;15(4):357–359. doi: 10.1111/j.1440-1681.1988.tb01087.x. [DOI] [PubMed] [Google Scholar]
  7. Dluhy R. G., Lifton R. P. Glucocorticoid-remediable aldosteronism. Endocrinol Metab Clin North Am. 1994 Jun;23(2):285–297. [PubMed] [Google Scholar]
  8. Dostal D. E., Baker K. M. Angiotensin II stimulation of left ventricular hypertrophy in adult rat heart. Mediation by the AT1 receptor. Am J Hypertens. 1992 May;5(5 Pt 1):276–280. doi: 10.1093/ajh/5.5.276. [DOI] [PubMed] [Google Scholar]
  9. Dzau V. J., Gibbons G. H., Cooke J. P., Omoigui N. Vascular biology and medicine in the 1990s: scope, concepts, potentials, and perspectives. Circulation. 1993 Mar;87(3):705–719. doi: 10.1161/01.cir.87.3.705. [DOI] [PubMed] [Google Scholar]
  10. Gohlke P., Linz W., Schölkens B. A., Kuwer I., Bartenbach S., Schnell A., Unger T. Angiotensin-converting enzyme inhibition improves cardiac function. Role of bradykinin. Hypertension. 1994 Apr;23(4):411–418. doi: 10.1161/01.hyp.23.4.411. [DOI] [PubMed] [Google Scholar]
  11. Griffin S. A., Brown W. C., MacPherson F., McGrath J. C., Wilson V. G., Korsgaard N., Mulvany M. J., Lever A. F. Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism. Hypertension. 1991 May;17(5):626–635. doi: 10.1161/01.hyp.17.5.626. [DOI] [PubMed] [Google Scholar]
  12. Gupta P., Franco-Saenz R., Mulrow P. J. Locally generated angiotensin II in the adrenal gland regulates basal, corticotropin-, and potassium-stimulated aldosterone secretion. Hypertension. 1995 Mar;25(3):443–448. doi: 10.1161/01.hyp.25.3.443. [DOI] [PubMed] [Google Scholar]
  13. Harrap S. B. Cardiovascular disease and genetics of the renin-angiotensin system. Heart. 1996 Nov;76(3 Suppl 3):13–17. doi: 10.1136/hrt.76.3_suppl_3.13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Harrap S. B., Nicolaci J. A., Doyle A. E. Persistent effects on blood pressure and renal haemodynamics following chronic angiotensin converting enzyme inhibition with perindopril. Clin Exp Pharmacol Physiol. 1986 Nov-Dec;13(11-12):753–765. doi: 10.1111/j.1440-1681.1986.tb02379.x. [DOI] [PubMed] [Google Scholar]
  15. Harrap S. B., Van der Merwe W. M., Griffin S. A., Macpherson F., Lever A. F. Brief angiotensin converting enzyme inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure long-term. Hypertension. 1990 Dec;16(6):603–614. doi: 10.1161/01.hyp.16.6.603. [DOI] [PubMed] [Google Scholar]
  16. Harris P. J., Young J. A. Dose-dependent stimulation and inhibition of proximal tubular sodium reabsorption by angiotensin II in the rat kidney. Pflugers Arch. 1977 Jan 17;367(3):295–297. doi: 10.1007/BF00581370. [DOI] [PubMed] [Google Scholar]
  17. Ishihata A., Endoh M. Species-related differences in inotropic effects of angiotensin II in mammalian ventricular muscle: receptors, subtypes and phosphoinositide hydrolysis. Br J Pharmacol. 1995 Jan;114(2):447–453. doi: 10.1111/j.1476-5381.1995.tb13247.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Iwai N., Shimoike H., Kinoshita M. Cardiac renin-angiotensin system in the hypertrophied heart. Circulation. 1995 Nov 1;92(9):2690–2696. doi: 10.1161/01.cir.92.9.2690. [DOI] [PubMed] [Google Scholar]
  19. Kim S., Ohta K., Hamaguchi A., Yukimura T., Miura K., Iwao H. Angiotensin II induces cardiac phenotypic modulation and remodeling in vivo in rats. Hypertension. 1995 Jun;25(6):1252–1259. doi: 10.1161/01.hyp.25.6.1252. [DOI] [PubMed] [Google Scholar]
  20. Linz W., Schaper J., Wiemer G., Albus U., Schölkens B. A. Ramipril prevents left ventricular hypertrophy with myocardial fibrosis without blood pressure reduction: a one year study in rats. Br J Pharmacol. 1992 Dec;107(4):970–975. doi: 10.1111/j.1476-5381.1992.tb13393.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Linz W., Schölkens B. A., Ganten D. Converting enzyme inhibition specifically prevents the development and induces regression of cardiac hypertrophy in rats. Clin Exp Hypertens A. 1989;11(7):1325–1350. doi: 10.3109/10641968909038172. [DOI] [PubMed] [Google Scholar]
  22. Mendelsohn F. A. A method for measurement of angiotensin II in tissues and its application to rat kidney. Clin Sci Mol Med. 1976 Aug;51(2):111–125. doi: 10.1042/cs0510111. [DOI] [PubMed] [Google Scholar]
  23. Miyata S., Haneda T. Hypertrophic growth of cultured neonatal rat heart cells mediated by type 1 angiotensin II receptor. Am J Physiol. 1994 Jun;266(6 Pt 2):H2443–H2451. doi: 10.1152/ajpheart.1994.266.6.H2443. [DOI] [PubMed] [Google Scholar]
  24. Morgan T., Davis J. M. Renin secretion at the individual nephron level. Pflugers Arch. 1975 Aug 29;359(1-2):23–31. doi: 10.1007/BF00581275. [DOI] [PubMed] [Google Scholar]
  25. Nicolantonio R. D., Spargo S., Morgan T. O. Prenatal high salt diet increases blood pressure and salt retention in the spontaneously hypertensive rat. Clin Exp Pharmacol Physiol. 1987 Mar;14(3):233–235. doi: 10.1111/j.1440-1681.1987.tb00381.x. [DOI] [PubMed] [Google Scholar]
  26. Pfeffer M. A., Braunwald E., Moyé L. A., Basta L., Brown E. J., Jr, Cuddy T. E., Davis B. R., Geltman E. M., Goldman S., Flaker G. C. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med. 1992 Sep 3;327(10):669–677. doi: 10.1056/NEJM199209033271001. [DOI] [PubMed] [Google Scholar]
  27. Rhaleb N. E., Yang X. P., Scicli A. G., Carretero O. A. Role of kinins and nitric oxide in the antihypertrophic effect of ramipril. Hypertension. 1994 Jun;23(6 Pt 2):865–868. doi: 10.1161/01.hyp.23.6.865. [DOI] [PubMed] [Google Scholar]
  28. Ruzicka M., Leenen F. H. Relevance of blockade of cardiac and circulatory angiotensin-converting enzyme for the prevention of volume overload-induced cardiac hypertrophy. Circulation. 1995 Jan 1;91(1):16–19. doi: 10.1161/01.cir.91.1.16. [DOI] [PubMed] [Google Scholar]
  29. Ruzicka M., Yuan B., Harmsen E., Leenen F. H. The renin-angiotensin system and volume overload-induced cardiac hypertrophy in rats. Effects of angiotensin converting enzyme inhibitor versus angiotensin II receptor blocker. Circulation. 1993 Mar;87(3):921–930. doi: 10.1161/01.cir.87.3.921. [DOI] [PubMed] [Google Scholar]
  30. Stoll M., Steckelings U. M., Paul M., Bottari S. P., Metzger R., Unger T. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest. 1995 Feb;95(2):651–657. doi: 10.1172/JCI117710. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Tiret L., Bonnardeaux A., Poirier O., Ricard S., Marques-Vidal P., Evans A., Arveiler D., Luc G., Kee F., Ducimetière P. Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet. 1994 Oct 1;344(8927):910–913. doi: 10.1016/s0140-6736(94)92268-3. [DOI] [PubMed] [Google Scholar]
  32. Yamazaki T., Komuro I., Shiojima I., Yazaki Y. The renin-angiotensin system and cardiac hypertrophy. Heart. 1996 Nov;76(3 Suppl 3):33–35. doi: 10.1136/hrt.76.3_suppl_3.33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Yuan B. X., Leenen F. H. Dietary sodium intake and left ventricular hypertrophy in normotensive rats. Am J Physiol. 1991 Nov;261(5 Pt 2):H1397–H1401. doi: 10.1152/ajpheart.1991.261.5.H1397. [DOI] [PubMed] [Google Scholar]
  34. Zhang Y., Morgan T. Effects of enalapril and Dup753 on renin synthesis in mice with one hydronephrotic kidney. Clin Exp Pharmacol Physiol. 1994 Feb;21(2):133–135. doi: 10.1111/j.1440-1681.1994.tb02481.x. [DOI] [PubMed] [Google Scholar]
  35. von Lutterotti N., Catanzaro D. F., Sealey J. E., Laragh J. H. Renin is not synthesized by cardiac and extrarenal vascular tissues. A review of experimental evidence. Circulation. 1994 Jan;89(1):458–470. doi: 10.1161/01.cir.89.1.458. [DOI] [PubMed] [Google Scholar]

Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES